Minimal clinically important differences in the brief pain inventory in patients with bone metastases

Supportive Care in Cancer

Volumn 21, Issue 7, 2013, Pages 1893-1899

  Wong, Karrie ^a   Zeng, Liang ^a   Zhang, Liying ^a   Bedard, Gillian ^a   Wong, Erin ^a   Tsao, May ^a   Barnes, Elizabeth ^a   Danjoux, Cyril ^a   Sahgal, Arjun ^a   Holden, Lori ^a   Lauzon, Natalie ^a   Chow, Edward ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Bone metastases; BPI; Brief pain inventory; Functional interference; MCID; Minimal clinically important difference; Pain

Indexed keywords

ANALGESIC AGENT; MORPHINE;

ARTICLE; BONE METASTASIS; BRIEF PAIN INVENTORY; CANCER LOCALIZATION; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; EFFECT SIZE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL CLINICAL IMPORTANT DIFFERENCE; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; SCORING SYSTEM; SLEEP DISORDER; TREATMENT RESPONSE; WALKING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT;

EID: 84878727417     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1731-9     Document Type: Article

References (14)

1. Twycross R, Harcourt J, Bergl S (1996) A survey of pain in patients with advanced cancer. J Pain Symptom Manage 12:273-282
2. Maringwa J, Quinten C, King M et al (2011) Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol 22:2107-2112
3. Cook C (2008) Clinimetrics corner: the minimal clinically important change score (MCID): a necessary pretense. J Man Manip Ther 16(4):E82-E83
4. Bedard G, Zeng L, Lam H et al (2012) Meaningful change in oncology quality of life instruments: a systematic literature review. Expert Rev Pharmacoecon Outcomes Res 12(4):475-483
5. Sloan J, Symonds T, Vargas-Chanes D, Fridley B (2003) Practical guidelines for assessing the clinical significant of health-related quality of life changes within clinical trials. Drug Inform J 37:23-32
6. Chow E, Hoskin P, Mitera G et al (2012) Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82:1730-1737
7. Cella D, Hahn EA, Dineen K (2002) Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res 11:207-221
8. Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health related quality-of-life scores. J Clin Oncol 16:139-144
9. Ringash J, O'Sullivan B, Bezjak A, Redelmeier DA (2007) Interpreting clinically significant changes in patient-reported outcomes. Cancer 110(1):196-202
10. Maringwa J, Quinten C, King M (2011) Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer 19(11):1753-1760
11. Wu C, Chuang L, Lin K et al (2011) Responsiveness, minimal detectable change, and minimal clinically important difference of the Nottingham extended activities of daily living scale in patients with improved performance after stroke rehabilitation. Arch Phys Med Rehabil 92:1281-1287
12. Walters S, Brazier J (2003) What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes 1:4
13. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582-592
14. Revicki D, Cella D, Hays R et al (2006) Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 4:70